Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor

Bioorganic & Medicinal Chemistry Letters - Tập 17 - Trang 587-592 - 2007
Rui Liang1, Lauren Abrardo1, Edward J. Brady2, Mari Rios Candelore3, Victor Ding3, Richard Saperstein2, Laurie M. Tota3, Michael Wright3, Steve Mock1, Constantin Tamvakopolous1, Sharon Tong1, Song Zheng1, Bei B. Zhang3, James R. Tata1, Emma R. Parmee1
1Department of Basic Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065 USA
2Department of Pharmacology, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA
3Department of Metabolic Disorders, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA

Tài liệu tham khảo

Zhang, 2000, Curr. Opin. Chem. Biol., 4, 461, 10.1016/S1367-5931(00)00103-4 Jiang, 2003, Am. J. Physiol., 284, E671 Sloop, 2004, Drugs Future, 29, 835, 10.1358/dof.2004.029.08.854175 Unger, 1978, Metabolism, 27, 1691, 10.1016/0026-0495(78)90291-3 Brand, 1994, Diabetologia, 37, 985, 10.1007/BF00400461 Brand, 1995, Am. J. Physiol., 269, E469 Brand, 1996, Diabetes, 45, 1076, 10.2337/diabetes.45.8.1076 Brand, 2000, Diabetes, 49, A81 Liang, 2004, Diabetes, 53, 410, 10.2337/diabetes.53.2.410 Sloop, 2004, J. Clin. Invest., 113, 1571, 10.1172/JCI20911 Petersen, 2001, Diabetologia, 44, 2018, 10.1007/s001250100006 Ling, 2002, Drugs Future, 27, 987, 10.1358/dof.2002.027.10.701362 Ling, 2003, Expert Opin. Ther. Patents, 13, 15, 10.1517/13543776.13.1.15 Kurukulasuriya, 2005, Expert Opin. Ther. Patents, 15, 1739, 10.1517/13543776.15.12.1739 Madsen, 1998, J. Med. Chem., 41, 5150, 10.1021/jm9810304 De Laszlo, 1999, Bioorg. Med. Chem. Lett., 9, 641, 10.1016/S0960-894X(99)00081-5 Chang, 2001, Bioorg. Med. Chem. Lett., 11, 2549, 10.1016/S0960-894X(01)00498-X Ladouceur, 2002, Bioorg. Med. Chem. Lett., 12, 3421, 10.1016/S0960-894X(02)00736-9 Madsen, 2002, J. Med. Chem., 45, 5755, 10.1021/jm0208572 Kurukulasuriya, 2004, Bioorg. Med. Chem. Lett., 14, 2047, 10.1016/j.bmcl.2004.02.056 Ling, A.; Plewe, M. B.; Truesdale, L. K.; Lau, J.; Madsen, P.; Sams, C.; Behrens, C.; Vagner, J.; Christensen, I. T.; Lundt, B. F.; Sidelmann, U. G.; Thøgersen, H. WO 00/69810, 2000. Jørgensen, A. S.; Christensen, I. T.; Kodra, J. T.; Madsen, P.; Behrens, C.; Sams, C.; Lau, J. WO 02/00612 A1, 2002. Qureshi, 2004, Diabetes, 53, 3267, 10.2337/diabetes.53.12.3267 Shen, 2005, Bioorg. Med. Chem. Lett., 15, 4564, 10.1016/j.bmcl.2005.06.101 The following patent also disclosed structures such as these. Kurukulasuriya, R.; Link, J. T.; Patel, J. R.; Sorensen, B. K. US 2004/0209928 A1, 2004. Koch, 1994, J. Org. Chem., 59, 1216, 10.1021/jo00084a050 Mayo, 2003, Pharmacol. Rev., 55, 167, 10.1124/pr.55.1.6 Dallas-Yang, 2004, Eur. J. Pharmacol., 501, 225, 10.1016/j.ejphar.2004.08.023 Brady, 2006, Diabetes, V55, P.A141